AstraZeneca plc vs Intel Corp — how do they compare? AstraZeneca plc trades at $158 (market cap $248.14B), while Intel Corp trades at $99.3 (market cap $492.85B). The key difference: Intel Corp is the larger of the two by market cap, and Intel Corp pays the higher dividend (2.24%). Which is the better fit depends on your goals.
| AZN | INTC | |
|---|---|---|
Market Cap | $248.14B | $492.85B |
Sector | Health | Technology |
52-Week High | $209.48 | $140.94 |
52-Week Low | $147.06 | $21.81 |
Enterprise Value | $275.41B | $513.66B |
Dividend Yield | 2.01% | 2.24% |
Volume | — | 43,552,012 |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →